ELEVANCE HEALTH INC (1ANTM.MI) Stock Fundamental Analysis
BIT:1ANTM - Euronext Milan - US0367521038 - Common Stock - Currency: EUR
1ANTM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 23 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of 1ANTM while its profitability can be described as average. 1ANTM has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
1ANTM had positive earnings in the past year.
1ANTM had a positive operating cash flow in the past year.
Each year in the past 5 years 1ANTM has been profitable.
In the past 5 years 1ANTM always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.12%, 1ANTM belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.
With a decent Return On Equity value of 14.47%, 1ANTM is doing good in the industry, outperforming 76.92% of the companies in the same industry.
1ANTM has a Return On Invested Capital of 6.52%. This is in the better half of the industry: 1ANTM outperforms 69.23% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ANTM is in line with the industry average of 5.35%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.12% | ||
| ROE | 14.47% | ||
| ROIC | 6.52% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
1ANTM has a Profit Margin of 3.38%. This is in the better half of the industry: 1ANTM outperforms 69.23% of its industry peers.
1ANTM's Profit Margin has declined in the last couple of years.
1ANTM has a Operating Margin (5.18%) which is in line with its industry peers.
In the last couple of years the Operating Margin of 1ANTM has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.18% | ||
| PM (TTM) | 3.38% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1ANTM is destroying value.
The number of shares outstanding for 1ANTM has been reduced compared to 1 year ago.
The number of shares outstanding for 1ANTM has been reduced compared to 5 years ago.
1ANTM has a worse debt/assets ratio than last year.
2.2 Solvency
1ANTM has a debt to FCF ratio of 6.96. This is a slightly negative value and a sign of low solvency as 1ANTM would need 6.96 years to pay back of all of its debts.
1ANTM has a Debt to FCF ratio (6.96) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.72 indicates that 1ANTM is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.72, 1ANTM is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | 6.96 | ||
| Altman-Z | N/A |
ROIC/WACC0.83
WACC7.9%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
1ANTM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.42%.
The Earnings Per Share has been growing by 11.17% on average over the past years. This is quite good.
The Revenue has been growing slightly by 3.19% in the past year.
Measured over the past years, 1ANTM shows a quite strong growth in Revenue. The Revenue has been growing by 11.14% on average per year.
EPS 1Y (TTM)-0.42%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-31.67%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%5.49%
3.2 Future
The Earnings Per Share is expected to grow by 14.21% on average over the next years. This is quite good.
Based on estimates for the next years, 1ANTM will show a quite strong growth in Revenue. The Revenue will grow by 8.90% on average per year.
EPS Next Y4.61%
EPS Next 2Y9.38%
EPS Next 3Y12.04%
EPS Next 5Y14.21%
Revenue Next Year9.96%
Revenue Next 2Y8.61%
Revenue Next 3Y8.9%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 11.40, the valuation of 1ANTM can be described as reasonable.
1ANTM's Price/Earnings ratio is rather cheap when compared to the industry. 1ANTM is cheaper than 88.46% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, 1ANTM is valued rather cheaply.
A Price/Forward Earnings ratio of 10.90 indicates a reasonable valuation of 1ANTM.
88.46% of the companies in the same industry are more expensive than 1ANTM, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. 1ANTM is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.4 | ||
| Fwd PE | 10.9 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1ANTM.
Based on the Price/Free Cash Flow ratio, 1ANTM is valued a bit more expensive than 73.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.05 | ||
| EV/EBITDA | 10.24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as 1ANTM's earnings are expected to grow with 12.04% in the coming years.
PEG (NY)2.47
PEG (5Y)1.02
EPS Next 2Y9.38%
EPS Next 3Y12.04%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.70%, 1ANTM has a reasonable but not impressive dividend return.
1ANTM's Dividend Yield is a higher than the industry average which is at 2.93.
1ANTM's Dividend Yield is slightly below the S&P500 average, which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.7% |
5.2 History
The dividend of 1ANTM is nicely growing with an annual growth rate of 15.34%!
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
25.22% of the earnings are spent on dividend by 1ANTM. This is a low number and sustainable payout ratio.
1ANTM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP25.22%
EPS Next 2Y9.38%
EPS Next 3Y12.04%
BIT:1ANTM (3/3/2025, 7:00:00 PM)
346.2
-21.4 (-5.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners91.45%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap78.71B
Analysts77.86
Price Target483.14 (39.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.7% |
Yearly Dividend6.03
Dividend Growth(5Y)15.34%
DP25.22%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.02%
Min EPS beat(2)-14.2%
Max EPS beat(2)0.17%
EPS beat(4)3
Avg EPS beat(4)-3.47%
Min EPS beat(4)-14.2%
Max EPS beat(4)0.17%
EPS beat(8)6
Avg EPS beat(8)-0.87%
EPS beat(12)9
Avg EPS beat(12)0.38%
EPS beat(16)12
Avg EPS beat(16)1.63%
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-0.71%
Max Revenue beat(2)2.1%
Revenue beat(4)1
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-1.1%
Max Revenue beat(4)2.1%
Revenue beat(8)4
Avg Revenue beat(8)0.76%
Revenue beat(12)7
Avg Revenue beat(12)0.69%
Revenue beat(16)9
Avg Revenue beat(16)0.39%
PT rev (1m)-8.32%
PT rev (3m)N/A
EPS NQ rev (1m)3.29%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.33%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)1.19%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.22%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.4 | ||
| Fwd PE | 10.9 | ||
| P/S | 0.48 | ||
| P/FCF | 19.05 | ||
| P/OCF | 14.88 | ||
| P/B | 2.07 | ||
| P/tB | 90.52 | ||
| EV/EBITDA | 10.24 |
EPS(TTM)30.37
EY8.77%
EPS(NY)31.77
Fwd EY9.18%
FCF(TTM)18.17
FCFY5.25%
OCF(TTM)23.26
OCFY6.72%
SpS716.31
BVpS167.38
TBVpS3.82
PEG (NY)2.47
PEG (5Y)1.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.12% | ||
| ROE | 14.47% | ||
| ROCE | 8.55% | ||
| ROIC | 6.52% | ||
| ROICexc | 7.07% | ||
| ROICexgc | 13.34% | ||
| OM | 5.18% | ||
| PM (TTM) | 3.38% | ||
| GM | N/A | ||
| FCFM | 2.54% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexcg growth 3Y-5.49%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | 6.96 | ||
| Debt/EBITDA | 2.8 | ||
| Cap/Depr | 90.17% | ||
| Cap/Sales | 0.71% | ||
| Interest Coverage | 7.39 | ||
| Cash Conversion | 54.43% | ||
| Profit Quality | 75.02% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score3
WACC7.9%
ROIC/WACC0.83
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.42%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-31.67%
EPS Next Y4.61%
EPS Next 2Y9.38%
EPS Next 3Y12.04%
EPS Next 5Y14.21%
Revenue 1Y (TTM)3.19%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%5.49%
Revenue Next Year9.96%
Revenue Next 2Y8.61%
Revenue Next 3Y8.9%
Revenue Next 5YN/A
EBIT growth 1Y-3.59%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year10.49%
EBIT Next 3Y11.08%
EBIT Next 5Y9.84%
FCF growth 1Y-33.69%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-28.77%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%